Evidence map›Paper›PMID 38982218›Full record

ArticleInternational journal of impotence research2025

A population analysis of delayed ejaculation using a claims database: characteristics and national trends in prevalence, incidence, and pharmacotherapy.

Brian Liao, Corey Able, Steven Banner, Clemens An, Ali A Nasrallah, Kevin Vu, Joseph Sonstein, Laith Alzweri, Taylor P Kohn

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of impotence research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brian LiaoJohn Sealy School of Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.ORCID http://orcid.org/0009-0008-4175-8156
Corey AbleDivision of Urology, Department of Surgery, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Steven BannerJohn Sealy School of Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Clemens AnThe Robert Larner M.D. College of Medicine, The University of Vermont, Burlington, VT, USA.
Ali A NasrallahDivision of Urology, Department of Surgery, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Kevin VuDivision of Urology, Department of Surgery, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.ORCID http://orcid.org/0000-0002-1288-147X
Joseph SonsteinDivision of Urology, Department of Surgery, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.ORCID http://orcid.org/0000-0003-0360-0522
Laith AlzweriDivision of Urology, Department of Surgery, The University of Texas Medical Branch at Galveston, Galveston, TX, USA.ORCID http://orcid.org/0000-0001-8467-2688
Taylor P KohnThe James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA. tkohn2@jhmi.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the prevalence, incidence, and rates of pharmacological treatment of delayed ejaculation using the TriNetX Diamond Network. We included all men evaluated in the inpatient, outpatient, and emergency settings. Prevalence was determined by comparing the number of men diagnosed with delayed ejaculation to the entire population. Incidence was determined by comparing the number of men diagnosed with delayed ejaculation without a prior diagnosis to the overall population without a prior diagnosis. Rates of pharmacologic treatment were calculated by comparing the number of men who received a prescription to the total number of men with delayed ejaculation. Trends in prevalence and incidence were compared using six-month intervals, while trends in pharmacologic treatment were compared using one-year intervals. A total of 23,164 adult males were diagnosed with delayed ejaculation from 2013 to 2019. During the final six-month interval (July to December 2019), 2,747 of 16,496,744 men received a delayed ejaculation diagnosis, and 1,375 of 16,488,270 men without a prior diagnosis were diagnosed with delayed ejaculation. In 2019, only 916 of 4,733 (19.4%) men diagnosed with delayed ejaculation received any prescription, with the most common being testosterone (9.5%), bupropion (6.6%), and buspirone (2.3%). Prevalence, incidence and pharmacologic treatment all had increasing trends.

Indexed as

EjaculationSexual Dysfunction, PhysiologicalAdultAgedBupropionDatabases, FactualEjaculatory DysfunctionHumansIncidenceMaleMiddle AgedPrevalenceTestosteroneUnited StatesYoung AdultBupropionTestosterone

Identifiers

PMID38982218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.